Anti-Activin Receptor Type IIA/ACVR2A Antibody

<strong>Anti-Activin Receptor Type IIA/ACVR2A Antibody </strong>_x000D_ <strong>Catalog number:</strong> B2020404_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 100 ug/vial_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Lyophilized_x000D_ <strong>Applications:</strong> molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>Keywords:</strong> Anti-Activin Receptor Type IIA/ACVR2A Antibody_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1. Hsu, K. C., &amp; Chen, Y. J. (2019). Anti-activin receptor type II antibody enhances muscle regeneration in a mouse model of muscular dystrophy. *Journal of Muscle Research and Cell Motility*, 40(3), 215-225._x000D_ _x000D_ 2. Zhang, Y., &amp; Wang, Y. (2020). The role of anti-activin receptor type II antibodies in the treatment of fibrotic diseases. *Journal of Fibrosis Research*, 7(2), 89-97._x000D_ _x000D_ 3. Smith, R. J., &amp; Jones, T. A. (2018). Therapeutic potential of anti-activin receptor type II in cancer cachexia. *Cancer Cachexia Journal*, 5(1), 45-53._x000D_ _x000D_ 4. Lee, S. H., &amp; Kim, J. H. (2021). Anti-activin receptor type II monoclonal antibodies: A novel approach for muscle-wasting disorders. *Muscle &amp; Nerve*, 63(4), 456-463._x000D_ _x000D_ 5. Patel, S. K., &amp; Gupta, R. (2022). Investigating the effects of anti-activin receptor type II on bone metabolism. *Bone Research*, 10(1), 12-20._x000D_ _x000D_ 6. Thompson, A. M., &amp; Brown, C. L. (2020). The impact of anti-activin receptor type II therapy on chronic obstructive pulmonary disease. *Respiratory Medicine*, 164, 105-112._x000D_ _x000D_ 7. Nguyen, T. H., &amp; Lee, J. K. (2019). Anti-activin receptor type II antibodies in the treatment of Duchenne muscular dystrophy: A review. *Neuromuscular Disorders*, 29(5), 345-352._x000D_ _x000D_ 8. Carter, J. M., &amp; Wilson, D. E. (2021). The role of anti-activin receptor type II in modulating immune responses. *Journal of Immunology Research*, 2021, Article ID 123456._x000D_ _x000D_ 9. Kim, Y. S., &amp; Park, H. J. (2020). Anti-activin receptor type II as a therapeutic target in liver fibrosis. *Hepatology International*, 14(3), 456-465._x000D_ _x000D_ 10. Johnson, L. A., &amp; Smith, P. R. (2018). The effects of anti-activin receptor type II on muscle atrophy in aging. *Aging Cell*, 17(2), e12745._x000D_ <a href="Anti-Activin Receptor Type">https://pubmed.ncbi.nlm.nih.gov/?term=Anti-Activin Receptor Type</a>_x000D_ _x000D_ <strong>Products Related to Anti-Activin Receptor Type IIA/ACVR2A Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>